Your browser doesn't support javascript.
loading
BMP4 promotes metastasis of hepatocellular carcinoma by an induction of epithelial-mesenchymal transition via upregulating ID2.
Zeng, Shan; Zhang, Yan; Ma, Junli; Deng, Ganlu; Qu, Yanlin; Guo, Cao; Han, Ying; Yin, Ling; Cai, Changjing; Li, Yiyi; Wang, Guqi; Bonkovsky, Herbert L; Shen, Hong.
Affiliation
  • Zeng S; Institute of Medical Sciences, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China; Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China; Key Laboratory for Molecular Radiation Oncology of Hunan Province, Xiangya Hospital, Central So
  • Zhang Y; Institute of Medical Sciences, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China; Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
  • Ma J; Institute of Medical Sciences, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China; Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
  • Deng G; Institute of Medical Sciences, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China; Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
  • Qu Y; Institute of Medical Sciences, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China; Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
  • Guo C; Institute of Medical Sciences, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China; Key Laboratory for Molecular Radiation Oncology of Hunan Province, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
  • Han Y; Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China; Key Laboratory for Molecular Radiation Oncology of Hunan Province, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
  • Yin L; Institute of Medical Sciences, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China; Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
  • Cai C; Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China; Key Laboratory for Molecular Radiation Oncology of Hunan Province, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
  • Li Y; Institute of Medical Sciences, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China; Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
  • Wang G; School of Medicine, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA.
  • Bonkovsky HL; School of Medicine, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA. Electronic address: hbonkovs@wakehealth.edu.
  • Shen H; Institute of Medical Sciences, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China; Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China; Key Laboratory for Molecular Radiation Oncology of Hunan Province, Xiangya Hospital, Central So
Cancer Lett ; 390: 67-76, 2017 04 01.
Article de En | MEDLINE | ID: mdl-28093286

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Régulation positive / Carcinome hépatocellulaire / Protéine d'inhibition de la différenciation-2 / Protéine morphogénétique osseuse de type 4 / Transition épithélio-mésenchymateuse / Tumeurs du foie Type d'étude: Prognostic_studies Limites: Female / Humans / Male / Middle aged Langue: En Journal: Cancer Lett Année: 2017 Type de document: Article Pays de publication: Irlande

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Régulation positive / Carcinome hépatocellulaire / Protéine d'inhibition de la différenciation-2 / Protéine morphogénétique osseuse de type 4 / Transition épithélio-mésenchymateuse / Tumeurs du foie Type d'étude: Prognostic_studies Limites: Female / Humans / Male / Middle aged Langue: En Journal: Cancer Lett Année: 2017 Type de document: Article Pays de publication: Irlande